Zoetis | ZTS - Pre Tax Profit

Stock Price
119.75
Daily Change
2.95 2.53%
Monthly
-2.13%
Yearly
-22.01%
Q2 Forecast
114.39

Zoetis reported $887M in Pre-Tax Profit for its fiscal quarter ending in September of 2025.





Pre Tax Profit Change Date
AbbVie USD 4.38B 1.92B Sep/2025
Align Technology USD 176.6M 81.86M Dec/2025
Bayer EUR -1.16B 735M Sep/2025
Bristol-Myers Squibb USD 3.11B 1.34B Sep/2025
Charles River Laboratories USD 170.03M 98.62M Sep/2025
Coherus Biosciences USD -46.35M 90.86M Dec/2025
Dentsply International USD -230M 77M Sep/2025
Eli Lilly USD 7.23B 456M Sep/2025
Henry Schein USD 137M 16M Sep/2025
Idexx Laboratories USD 306.98M 37.79M Dec/2025
Illumina USD 220M 86M Sep/2025
IQVIA Holdings USD 6.16B 5.84B Sep/2025
J&J USD 4.97B 2.53B Dec/2025
Laboratory Of America USD 337M 32.3M Sep/2025
Merck USD 6.74B 22M Sep/2025
Neogen USD 28M 15.81M Sep/2025
Pacira USD 9.52M 11.45M Sep/2025
Perrigo USD 22.4M 19.2M Sep/2025
Pfizer USD 3.33B 290M Sep/2025
Phibro Animal Health USD 38.62M 1.26M Dec/2025
Quest Diagnostics USD 336M 57M Sep/2025
Sanofi EUR -1.16B 5.5B Dec/2025
Sanofi EUR -1.16B 6.23B Dec/2025
Zoetis USD 887M 15M Sep/2025